LivaNova (NASDAQ:LIVN) Shares Gap Down - Time to Sell?

LivaNova PLC (NASDAQ:LIVN - Get Free Report)'s share price gapped down prior to trading on Thursday . The stock had previously closed at $35.07, but opened at $34.13. LivaNova shares last traded at $34.89, with a volume of 56,866 shares changing hands.

Analyst Ratings Changes

A number of research firms have commented on LIVN. Needham & Company LLC restated a "buy" rating and issued a $64.00 price objective on shares of LivaNova in a research note on Monday, March 17th. Mizuho cut their price target on LivaNova from $70.00 to $60.00 and set an "outperform" rating for the company in a research note on Wednesday, February 26th. Barclays dropped their price objective on shares of LivaNova from $58.00 to $56.00 and set an "equal weight" rating on the stock in a research note on Friday, March 7th. Stifel Nicolaus dropped their price target on shares of LivaNova from $72.00 to $60.00 and set a "buy" rating on the stock in a research note on Wednesday, February 26th. Finally, StockNews.com upgraded LivaNova from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, March 25th. Two analysts have rated the stock with a hold rating, five have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, LivaNova presently has an average rating of "Buy" and an average price target of $61.17.

LivaNova Stock Up 0.9 %

The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46. The firm's fifty day simple moving average is $40.59 and its 200-day simple moving average is $47.00. The company has a market cap of $1.92 billion, a PE ratio of 84.29 and a beta of 0.90.

Hedge Funds Weigh In On LivaNova

Several institutional investors and hedge funds have recently modified their holdings of the company. Russell Investments Group Ltd. increased its stake in shares of LivaNova by 17.1% during the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock valued at $70,000 after acquiring an additional 219 shares during the last quarter. Summit Investment Advisors Inc. raised its holdings in shares of LivaNova by 1.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 16,846 shares of the company's stock valued at $780,000 after buying an additional 289 shares during the period. Central Pacific Bank Trust Division lifted its position in shares of LivaNova by 7.0% during the first quarter. Central Pacific Bank Trust Division now owns 4,407 shares of the company's stock worth $173,000 after purchasing an additional 290 shares in the last quarter. Xponance Inc. grew its stake in shares of LivaNova by 6.1% during the fourth quarter. Xponance Inc. now owns 7,762 shares of the company's stock valued at $359,000 after acquiring an additional 445 shares in the last quarter. Finally, Mariner LLC increased its holdings in LivaNova by 8.4% during the 4th quarter. Mariner LLC now owns 5,741 shares of the company's stock worth $266,000 after purchasing an additional 446 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.